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Introduction
Schizophrenia is a highly heritable polygenic disorder (1) . Collectively, common variants contribute up to half of the genetic variance in schizophrenia liability (2, 3) , and 145 distinct loci have currently been associated with the disorder at genome-wide levels of significance in the most recent genome-wide association study (4) .
Schizophrenia risk is also conferred by rare mutations, including copy number variants (CNVs) (5, 6) and rare coding variants (RCVs) (7, 8) , each of which sometimes occur as de novo mutations (9, 10) .
Studies of RCVs have the potential to inform schizophrenia pathogenesis since they can pinpoint specific functional variants in individual genes. However, only two genes, SETD1A (11) and RBM12 (12) , have been strongly implicated. A major limiting factor, as for studies of common variants, is that for complex disorders, large samples are required to obtain robust results in case-control studies (13) . To date, the largest published sequencing studies of schizophrenia have involved around 5,000 cases, 9,000 controls and 1,000 parent-proband trios (7, 11) , almost an order of magnitude smaller than recently published schizophrenia SNP genotyping studies of common risk variants (e.g. 40,675 cases and 64,643 controls (4)). Nevertheless, exome sequencing studies have provided important clues to the pathophysiology of schizophrenia. For example, proband-parent trio based studies have shown de novo RCVs to be significantly enriched among glutamatergic post-synaptic proteins, in M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 datasets (7, 8) . More recently, in an extension of the Swedish sample used by Purcell et al 2014 (8) , the authors documented an elevated exome-wide burden of ultra-rare, protein disruptive variants, which was concentrated among 3,388 neuron-specific genes, particularly those that are expressed at synapses, including the ARC and NMDAR complexes (7) . Additionally, the enrichment of RCVs in schizophrenia has been shown to be concentrated among 3,488 genes that are depleted for loss-offunction (LoF) mutation in large population cohorts (15, 16) .
In the current study, we performed targeted sequencing of 187 genes, selected for prior evidence for association with schizophrenia ( Supplementary Table S1 ), in 5,207 cases and 4,991 controls, none of which have contributed to previous schizophrenia sequencing studies. Among these targeted genes, we had complete membership of four gene sets; ARC and NMDAR post-synaptic protein complexes, which have been strongly implicated in multiple previous studies (9, 10) , and voltagegated sodium (17) and calcium channels (8) , which have inconclusive evidence for association with schizophrenia in previous rare variant studies (7, 17) . The remainder of the genes targeted for sequencing were selected on the basis of supportive evidence from at least two sources (see methods). Our primary aims were to a) test for enrichment of RCVs in all 187 targeted genes, b) test for enrichment of RCVs in four candidate gene-sets previously implicated in schizophrenia, and c) identify individual genes significantly enriched for RCVs.
Most recent studies of RCVs in schizophrenia have focused on LoF variants. However, it is clear that missense variants also contribute to schizophrenia risk (7, 9) , but in contrast to LoF variants, in silico methods cannot distinguish at high sensitivity and specificity between missense variants that alter the function of the encoded protein and those that are benign. Recently, it has been shown that restricting analyses
to missense variants affecting amino-acids that are conserved within paralogous gene families improves power for identifying pathogenic variants (18) . Given that two of our targeted gene sets consist of paralogous gene families (voltage-gated sodium and calcium channels), we exploited this approach in a secondary analysis of paralog conserved missense variants (18) .
Finally, to maximise power, we meta-analysed the new sequencing data with independent, published schizophrenia case-control (Swedish (7) and UK10K (11) datasets) and trio exome-sequencing data (see methods), yielding a combined analysis of RCVs in a total of 11,319 cases, 15,854 controls and 1,136 trios.
Methods and Materials

Ethics statement
All research conducted as part of this study was consistent with UK regulatory and ethical guidelines. We gained national NHS research ethics committee approval for the CLOZUK (10 /WSE02/15) and Cardiff COGS (07/WSE03/110) studies. The control samples were recruited as part of independent projects all of which have equivalent ethical permissions and data sharing procedures in place.
Sample description
Targeted sequence sample: A total of 11,493 blood-derived DNA samples were selected for targeted sequencing (5,724 cases and 5,769 controls). None have been included in previous schizophrenia sequencing studies. The majority of sequenced cases were from the CLOZUK dataset (n=4,647), which has been described previously (19) and in the Supplementary Material. We sequenced additional cases
from the UK (Cardiff COGS cohort; n=521), Ireland (Dublin cohort; n=335) and the Netherlands (GROUP cohort (20) ; n=221). We sequenced UK controls from the WTCCC2 consortium (1958 birth cohort n=2,860, UK blood donors n = 2,463) (21) (22) (23) . Additional controls were sequenced from the Dublin (n= 230) and GROUP cohorts (n=216) (20) . Sample descriptions are presented in the Supplementary Material.
Additional data sets:
We acquired publically available case-control exome sequencing data from the UK10K study (N=1,352 cases and 4,769 controls) (11) and a Swedish study (N= 4,867 cases and 6,140 controls) (7) . De novo mutations from 1,136 published schizophrenia-proband parent trios were derived from published studies (9, 24-31) (Supplementary Material Table S8 ).
Power calculations for our final sample size are presented in the Supplementary Material (Table S11) .
Gene-selection
We used Ion Torrent instruments to sequence the coding regions of genes belonging to the following gene sets: ARC (n=28) (9), NMDAR (n=61) (9), voltage-gated calcium channels (n=26) (8) and voltage-gated sodium channels (n=14) (17) . We sequenced an additional 58 genes, selected for having two or more supportive lines of evidence for association with schizophrenia (full criteria for gene-selection described in Supplementary Material and Table S1)
Data processing and quality control
The protocols used for targeted sequencing, data processing and quality control are presented in the Supplementary material. Briefly, raw sequence reads were
independently processed for each Ion Torrent wave according to GATK best practice guidelines (32, 33) . We excluded samples that were outliers from their sequencing wave's mean for: proportion of variants in dbSNP; number of alternative alleles; number of singletons; number of synonymous mutations; number of nonsynonymous mutations. For 96% (5,508/5,724) of cases and 72% (4,149/5,769) of controls, we used available array data to identify and remove duplicate and 1 st degree relatives and samples with a genotype concordance < 0.9. For samples not previously genotyped, 
Statistics
Gene set and single gene association statistics for case-control data were generated using the following Firth's penalised-likelihood logistic regression model:
Logit (pr(case)) ~ N test variants + baseline synonymous count + first 10 PCs + sex + Ion Torrent sequencing wave (targeted analysis only). P-values from the above models were compared to those generated in the same manner from 100,000 random permutations of case-control labels in our datasets.
Enrichment for de novo mutations was tested using the statistical framework number of de novo mutations using a Poisson test. A full description of our statistical approach for the above tests, and the case-control-de novo meta-analysis, can be found in the Supplementary Material.
Approach to hypothesis testing and multiple testing
Here we outline our main enrichment tests and our approach for correcting for multiple testing (further details in Supplementary Material). We first tested for the enrichment of RCVs in all 187 genes by performing 6 burden tests (LoF, nonsynonymous damaging, and nonsynonymous variant annotations under two allele frequency thresholds (<0.1% and singletons)). The derived P-values were Bonferroni corrected for 6 tests. We then performed an exploratory analysis to further characterize any observed enrichments, by partitioning the targeted genes into those intolerant of LoF variants (pLi > 0.9) and those that are not (pLi ≤ 0.9). Since this later analysis was exploratory, no multiple testing correction was applied.
In our primary case-control gene set analysis, we had data for four sets; two synaptic sets (ARC and NMDAR) and two ion channel sets (voltage-gated sodium channels and voltage-gated calcium channels). These were tested for enrichment of rare (<0.1% frequency) LoF variants, as this was the only class of mutation enriched among all 187 genes after correction for multiple testing (see results). The P-values derived from our new targeted sequencing sample were therefore Bonferroni corrected for four tests (four gene-sets x one mutation class).
For meta-analysis, we note the inclusion of ARC, NMDAR, and calcium channel gene sets in the present study was predicated on previous associations from exome-wide de novo and case-control studies that are included in the present metaanalysis (8, 9) . This ascertainment bias makes it impossible to generate meaningful
and appropriately conservative study-wide multiple-testing corrections. We therefore consider those meta-analyses as representing an appraisal of the current sequencing evidence for those gene-sets. The case-control meta-analysis of sodium channels does not include any previously reported data, and therefore it does not suffer from such an ascertainment bias; accordingly, we calculate study-wide corrected P-values as we did for the new sequencing data (four gene-sets x one mutation class).
For the secondary analysis of LoF variants and missense variants at paralog conserved sites, although this was only apropriate for the two ion-channel gene-sets, aiming to be conservative, we Bonferroni corrected for 8 potential tests (four genesets x two mutation classes). To dissect the observed enrichment of LoF and missense variants at paralog conserved sites in sodium channels (see results), we partioned them into alpha and beta subunits. Aiming to favour caution in the light of the novelty of the finding, we conservatively Bonferroni corrected the derived P-values for 12 potential tests (two mutation classes tested against four gene-sets plus the two subsets of sodium channel alpha and beta subunits).
For single-gene enrichment analysis of rare (< 0.1% frequency) LoF variants, we applied exome-wide criteria for multiple testing correction by Bonferroni correcting P-values for 20,000 tests.
Results
Mutation burden
In the targeted sequence sample, we performed six primary tests of mutation burden across all 187 targeted genes: LoF, nonsynonymous damaging and nonsynonymous variants, each under two allele frequency thresholds; < 0.1% and singletons.
Correcting for six tests, we observed a significant (P corrected < 0.05) excess of LoF mutations (< 0.1% frequency) in cases (Table 1) , who had a mean excess of 0.013 LoF mutations per person across the 187 targeted genes ( Supplementary Table S2 ).
Similar results were obtained by permutation analysis (P = 0.0013; P corrected = 0.0078).
There was no significant difference between cases and controls for any other class of variant ( Table 1 ). As part of our QC, we note no difference between cases and controls in the rate of synonymous mutation at the same frequency (<0.1%; OR (95% CI) = 1.02 (0.94-1.08); P = 1), suggesting the enrichment of LoF mutations in cases is unlikely to be due to technical artefacts. Table 1 about here Meta-analysis with two previously published case-control exome sequencing datasets (Sweden and UK10K) strengthened the evidence for an increase in LoF variants (frequency <0.1%) in the set of 187 genes in cases (Table 1 and Supplementary Table S3 ).
We partitioned the 187 genes into those intolerant of LoF variants (pLi scores > 0.9 in nonpsych-ExAC data (15) ) and those that are not intolerant (pLi ≤ 0.9). Metaanalysis of the case-control data showed that association between schizophrenia and rare (frequency <0.1%) LoF variants was stronger in LoF intolerant genes (Table 1; Z-test difference in effect size P = 0.0006).
Gene set analysis
Primary analysis of voltage-gated sodium and calcium channels: We found nominally significant evidence for enrichment in cases for LoF variants (<0.1% frequency) in voltage-gated sodium channels (targeted sequencing sample; OR (95% CI) = 1.99 (1.11-3.71); P = 0.02; P corrected = 0.08; case-control-de novo meta-analysis: Supplementary Table S4 ), but no evidence for association between schizophrenia and voltage-gated calcium channels ( Supplementary Table   S4 ).
Secondary analysis of paralog conserved ion channel sites:
In the targeted sequence sample, we found a significant case excess of rare (frequency <0.1%) paralog conserved missense and LoF variants in sodium channels (OR (95% CI) = 1.26 (1.08-1.47); P = 0.0035; empirical P = 0.0034; P corrected = 0.027) but not calcium channels ( Supplementary Table S5 ). This enrichment was also supported in the full case-control meta-analysis (OR (95% CI) = 1.18 (1.07-1.31); P = 0.0014; P corrected = 0.011, Figure 1 , Supplementary Table S5 ).
The following exploratory analyses were conducted to test the robustness of the enrichment of paralog conserved missense and LoF variants in sodium channels.
We found evidence that the sodium channel enrichment does not simply reflect a general increased burden for LoF variants and missense variants at paralog sites, as it is significantly greater than sets of genes of equivalent size sampled randomly from the non-sodium channel component of our targeted gene set (P = 0.0037, see Supplementary Material for details). Additionally, the enrichment observed for sodium channels was significantly greater (P = 0.016) than random sets of genes sampled from all targeted paralogous genes (i.e. including sodium channels among the genes randomly sampled). An enrichment with a similar effect size was also observed after the exclusion of LoF variants (case-control meta-analysis: OR (95% M A N U S C R I P T
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13 CI) = 1.16 (1.04-1.29); P = 0.007), discounting the possibility that the additonal evidence provided by our analysis of paralog conserved sites in sodium channels was merely a re-presentation of the earlier primary finding of a nominal enrichment for LoF variants. As a further control for sequence quality, we found the effect size for rare (frequency <0.1%) paralog conserved missense and LoF variants was significantly different from that for paralog non-conserved missense variants (Z-test P = 0.0018), indeed, as a negative control, there was no enrichment for missense variants at paralog non-conserved sites (case-control meta-analysis P = 0.44, Figure 1 , Supplementary Table S5 ).
Figure 1 about here
To dissect the voltage-gated sodium channel association, we divided the genes into their two primary functional groupings, alpha (10 genes) and beta (4 genes) subunits, testing these separately. Only the alpha subunits were significantly enriched for rare (frequency <0.1%) paralog conserved missense and LoF variants (Casecontrol meta-analysis: Alpha subunits, OR (95% CI) = 1.2 (1.08-1.33); P = 0.00086; P corrected = 0.01; Beta subunits, OR (95% CI) = 0.92 (0.52-1.62); P uncorrected = 0.76). In all sodium channel genes, a single nonsense de novo mutation was observed, that being in SCN2A (de novo P value for LoF and paralog conserved missense variants in sodium channel alpha subunits = 0.75; case-control-de novo meta-analysis: P = 0.0029; P corrected = 0.035).
Paralog conserved analysis did not reveal association with schizophrenia for individual voltage-gated sodium channel genes at the level required to demonstrate association (i.e. exome-wide significance) ( Supplementary Table S6) OR=1.66 (1.05-2.69) sets ( Figure 2 ). When meta-analysed with published casecontrol datasets, we found strong evidence that LoF variants in NMDAR complex genes were associated with schizophrenia (P = 1.6 x 10 -4 , Figure 2 and Supplementary   Table S4 ), but weaker evidence for association with ARC complex genes (P = 0.047, Figure 2 and Supplementary Table S4 ).
Figure 2 about here
To summarize the current status of RCVs in the above gene sets, we combined the case-control meta-analysis data with the de novo variant data, selecting the class of de novos reported to be most strongly enriched in these gene sets (nonsynonymous de novo variants in ARC and LoF de novo variants NMDAR) in previous work (9) . In the trio data, nonsynonymous and LoF de novo variants were associated with ARC (P = 0.0015) and NMDAR (P = 0.014), respectively. Combining the de novo enrichment results with the case-control meta-analysis results (LoF, frequency < 0.1%), both ARC (P = 4.0 x 10 -4 ) and NMDAR (P = 1.7 x 10 -5 ) were associated with schizophrenia ( Table 2) .
The ARC and NMDAR complexes share 9 overlapping genes: when excluded from the analysis, we observed independent evidence for association with both gene 
Single gene analysis
In the primary meta-analysis (LoF; frequency <0.1%) of all data, no gene was associated with schizophrenia after Bonferroni correction ( Supplementary Table S7 ).
The most significant gene was TAF13 (P = 1.6 x 10 -5 ), support coming mainly from published LoF de novo variants as noted before (9) .
Discussion
Sequencing studies have started to provide novel insights into the genetic architecture and aetiology of schizophrenia, although these are still limited by small sample sizes and low power. Seeking to increase power for a prioritized set of genes, we sequenced the coding regions of 187 schizophrenia candidates in over 10,000 samples that have not contributed to previous sequencing studies of schizophrenia.
Across all candidates, we found a significant excess of LoF variants in the independent samples, confirming our hypothesis that one or more of the candidates is involved in schizophrenia pathogenesis. The strongest evidence for enrichment was for LoF variants with a frequency <0.1%, suggesting that recurrent rather than only singleton schizophrenia risk variants are present among our 187 targeted genes. This appears to contrast with a Swedish exome-sequencing study of schizophrenia, which reported an increased exome-wide burden in cases of ultra-rare protein altering M A N U S C R I P T
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16 variants observed only once in their sample and never in 45,376 non-psychiatric ExAC individuals (7) . Our analyses of the same Swedish dataset ( Supplementary   Table S10 ) agrees with the primary study that at the exome-wide level, singleton LoF variants are more highly enriched than recurrent variants with a frequency <0.1% (Ztest P = 0.00035). However, this did not hold when restricted to the 187 targeted genes (Z-test P = 0.11) we have selected. Evidence for non-singleton variants being enriched among specific sets of genes has been demonstrated in a recent analysis of the same Swedish data (35) .
RCVs were enriched in our targeted genes with modest effect sizes when compared with specific rare variants previously associated with schizophrenia (e.g.
CNVs). This may be a consequence of including variants in our burden analyses that
are not related to schizophrenia, thus underestimating the effect size of causal variants. This limitation is inherent in sequencing studies, and will only be overcome when true risk variants are known.
Among our sequenced genes were 14 voltage-gated sodium channels, which as a set were previously associated with schizophrenia in an analysis of parentproband trios for compound heterozygous mutation, although this did not replicate (17) . Rare variants in sodium channels have been associated with additional neurodevelopmental disorders, including some forms of epilepsy and developmental delay (18, 36, 37) , which gives high plausibility that varaints in these genes could also increase risk of schizophrenia. Given equivocal findings from previous studies implicating sodium channels in schizophrenia (17) , our results provide novel evidence for association between RCVs in sodium channels and schizophrenia. We provide evidence that both LoF and missense variants at paralog conserved sites in sodium channels increase risk of schizophrenia. This supports previous work that showed M A N U S C R I P T
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paralog conservation scores can effectively identify missense variants associated with neurodevelopmental disorders (18) .
The sodium channel set contains 14 genes, 10 encoding alpha subunits involved in generating action potentials (36) , and 4 beta subunits which, in association with alpha subunits, modulate their gating and cellular excitability (37) . In our analysis, the evidence for association derives from variants in alpha subunits, although the absence of signal in beta-subunits might simply reflect low power (there are fewer beta-subunits, of which paralog conservation scores are only available for SCN2B and SCN4B, whereas paralog conservation scores are available for all 10 alpha subunits).
The statistical evidence we report for association with sodium channels survived a study-wide Bonferroni correction for multiple testing, was robust to permutation testing, and has high plausibility in the context of sodium channel associations in other neurodevelopmental disorders; nevertheless, despite our use of virtually all published sequencing data that are publically available, it will be necessary for future studies to confirm this before the finding can be considered definitive.
In the present study, we conducted the largest schizophrenia sequencing metaanalysis of RCVs in the synaptic gene sets ARC and NMDAR to date. The inclusion of our new independent data in this analysis strengthened the evidence for association between RCVs in ARC and NMDAR and schizophrenia. In the context of previously published research, where rare and de novo CNVs in these gene sets have been consistently associated with schizophrenia (5, 10, 14) , the results now provide a strong and consistent body of evidence for the involvement of ARC and NMDAR proteins in the aetiology of schizophrenia.
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Despite the increased sample size, we did not observe any single-gene association that was significant at a genome-wide significant level, or even a studywide level, and therefore it is not possible to infer causal associations between any of the variants, or genes, presented in this study. Doing so will require even larger samples, and possibly other methods for classifying missense variation.
In our new targeted sequence sample, ~81% of cases were from the CLOZUK cohort, a cohort of individuals whose phenotype comprises a clinician reported diagnosis of treatment resistant schizophrenia (TRS) requiring clozapine treatment.
The CLOZUK cohort has been previously validated (see Supplementary note in (4)), and has a similar common and CNV variant architecture to schizophrenia samples diagnosed using research instruments (6) . This sample is likely to be over represented for certain features including increased severity, poorer cognition, early onset, and (by definition) treatment resistance, but we are unable to examine the impact these phenotypes may have had on our results. It is therefore possible that our findings reflect association to those phenotypic aspects of the disorder rather than liability in general. Moreover, as many of our controls (N=2,463) are blood donors, these are likely to be psychiatrically healthier than the general population. These sampling frameworks enhance power for discovery, but a corollary is it is likely to inflate effect sizes, and therefore follow-up studies in general population samples are required.
Differences in allele frequencies caused by phenotypes associated with TRS would most likely be observed in LoF intolerant genes, given their consistent association with severe neurodevelopmental phenotypes (16, 38) . However, we find no evidence of heterogeneity in our case-control meta-analysis of rare, LoF variants in all 106 In conclusion, we conducted one of the largest sequencing studies of schizophrenia to date, which targeted the protein coding regions of 187 putative schizophrenia risk genes. By leveraging information from paralog conservation, we provide novel evidence that multiple voltage-gated sodium channels are involved in schizophrenia pathogenesis. We provide further support for association between RCVs in ARC and NMDAR post-synaptic protein complexes and schizophrenia.
While it is premature to speculate on the mechanistic and therapeutic implications of the current findings, we note the implication of sodium channel genes adds to evidence, including previous work implicating post-synaptic protein complexes, pointing to fundamental abnormalities of neuronal activity in schizophrenia as well as suggesting the possibility that these may be tractable to novel and existing pharmacological approaches. Table 2 . Synaptic gene set meta-analysis.
The case-control meta-analysis tested LoF variants (frequency <0.1%) for ARC and NMDAR in 11,319 schizophrenia cases and 15,854 controls. The de novo analysis tested nonsynonymous and LoF variants in ARC and NMDAR, respectively, in 1,136 schizophrenia trios. Full details of the analysis are presented in Supplementary Table   S4 . We note that the P-values reported here are uncorrected (see methods for rationale). 
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